(jatkuu) SARS2 ja AGE2 tutkimuksen tuoreita referenssejä

References

1. 1.↵
   Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, China Novel Coronavirus I, Research T. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020. doi: 10.1056/NEJMoa2001017. PubMed PMID: 31978945.

   CrossRefPubMedGoogle Scholar
2. 2.↵
   Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020. Epub 2020/02/06. doi: 10.1038/s41586-020-2012-7. PubMed PMID: 32015507.

   CrossRefPubMedGoogle Scholar
3. 3.↵
   Gallagher TM, Buchmeier MJ. Coronavirus spike proteins in viral entry and pathogenesis. Virology. 2001;279(2):371–4. doi: 10.1006/viro.2000.0757. PubMed PMID: 11162792.

   CrossRefPubMedWeb of ScienceGoogle Scholar
4. 4.↵
   Simmons G, Zmora P, Gierer S, Heurich A, Pohlmann S. Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. Antiviral Res. 2013;100(3):605–14. doi: 10.1016/j.antiviral.2013.09.028. PubMed PMID: 24121034; PMCID: PMC3889862.

   CrossRefPubMedWeb of ScienceGoogle Scholar
5. 5.↵
   Belouzard S, Chu VC, Whittaker GR. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci U S A. 2009;106(14):5871–6. doi: 10.1073/pnas.0809524106. PubMed PMID: 19321428; PMCID: PMC2660061.

   Abstract/FREE Full TextGoogle Scholar
6. 6.↵
   Li F, Li W, Farzan M, Harrison SC. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 2005;309(5742):1864–8. doi: 10.1126/science.1116480. PubMed PMID: 16166518.

   Abstract/FREE Full TextGoogle Scholar
7. 7.↵
   Millet JK, Whittaker GR. Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis. Virus Res. 2015;202:120–34. doi: 10.1016/j.virusres.2014.11.021. PubMed PMID: 25445340; PMCID: PMC4465284.

   CrossRefPubMedGoogle Scholar
8. 8.↵
   Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, Bates P. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci U S A. 2005;102(33):11876–81. doi: 10.1073/pnas.0505577102. PubMed PMID: 16081529; PMCID: PMC1188015.

   Abstract/FREE Full TextGoogle Scholar
9. 9.↵
   Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–4. doi: 10.1038/nature02145. PubMed PMID: 14647384.

   CrossRefPubMedGoogle Scholar
10. 10.
    Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell M, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C, Penninger JM. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875–9. doi: 10.1038/nm1267. PubMed PMID: 16007097.

    CrossRefPubMedWeb of ScienceGoogle Scholar
11. 11.↵
    Hoffmann M, Kleine-Weber H, Krüger N, Müller M, Drosten C, Pöhlmann S. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv. 2020.

    Google Scholar   https://www.biorxiv.org/content/10.1101/2020.01.31.929042v1.abstract
12. 12.↵
    Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, Graham BS, McLellan JS. Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation. bioRxiv. 2020.

    Google Scholar
13. 13.↵
    Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000;87(5):E1–9. doi: 10.1161/01.res.87.5.e1. PubMed PMID: 10969042.

    CrossRefPubMedWeb of ScienceGoogle Scholar
14. 14.
    Zhang H, Kang Z, Gong H, Xu D, Wang J, Li Z, Cui X, Xiao J, Meng T, Zhou W, Liu J, Xu H. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. bioRxiv. 2020.

    Google Scholar
15. 15.↵
    Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv. 2020.

    Google Scholar
16. 16.↵
    Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-dos-Santos AJ, da Costa J, Zhang L, Pei Y, Scholey J, Ferrario CM, Manoukian AS, Chappell MC, Backx PH, Yagil Y, Penninger JM. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417(6891):822–8. doi: 10.1038/nature00786. PubMed PMID: 12075344.

    CrossRefPubMedWeb of ScienceGoogle Scholar
17. 17.
    Raizada MK, Ferreira AJ. ACE2: a new target for cardiovascular disease therapeutics. J Cardiovasc Pharmacol. 2007;50(2):112–9. doi: 10.1097/FJC.0b013e3180986219. PubMed PMID: 17703127.

    CrossRefPubMedWeb of ScienceGoogle Scholar
18. 18.↵
    Zisman LS, Keller RS, Weaver B, Lin Q, Speth R, Bristow MR, Canver CC. Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2. Circulation. 2003;108(14):1707–12. doi: 10.1161/01.CIR.0000094734.67990.99. PubMed PMID: 14504186.

    Abstract/FREE Full TextGoogle Scholar
19. 19.↵
    Zhang H, Wada J, Hida K, Tsuchiyama Y, Hiragushi K, Shikata K, Wang H, Lin S, Kanwar YS, Makino H. Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. J Biol Chem. 2001;276(20):17132–9. doi: 10.1074/jbc.M006723200. PubMed PMID: 11278314.

    Abstract/FREE Full TextGoogle Scholar
20. 20.↵
    Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus AD, Timens W, Turner AJ, Navis G, van Goor H. The emerging role of ACE2 in physiology and disease. J Pathol. 2007;212(1):1–11. doi: 10.1002/path.2162. PubMed PMID: 17464936.

    CrossRefPubMedWeb of ScienceGoogle Scholar
21. 21.↵
    Towler P, Staker B, Prasad SG, Menon S, Tang J, Parsons T, Ryan D, Fisher M, Williams D, Dales NA, Patane MA, Pantoliano MW. ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J Biol Chem. 2004;279(17):17996–8007. doi: 10.1074/jbc.M311191200. PubMed PMID: 14754895.

    Abstract/FREE Full TextGoogle Scholar
22. 22.↵
    Song W, Gui M, Wang X, Xiang Y. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathog. 2018;14(8):e1007236. doi: 10.1371/journal.ppat.1007236. PubMed PMID: 30102747; PMCID: PMC6107290.

    CrossRefPubMedGoogle Scholar
23. 23.↵
    Kirchdoerfer RN, Wang N, Pallesen J, Wrapp D, Turner HL, Cottrell CA, Corbett KS, Graham BS, McLellan JS, Ward AB. Receptor binding and proteolysis do not induce large conformational changes in the SARS-CoV spike. bioRxiv. 2018.

    Google Scholar
24. 24.↵
    Kowalczuk S, Broer A, Tietze N, Vanslambrouck JM, Rasko JE, Broer S. A protein complex in the brush-border membrane explains a Hartnup disorder allele. FASEB J. 2008;22(8):2880–7. doi: 10.1096/fj.08-107300. PubMed PMID: 18424768.

    CrossRefPubMedWeb of ScienceGoogle Scholar
25. 25.↵
    Seow HF, Broer S, Broer A, Bailey CG, Potter SJ, Cavanaugh JA, Rasko JE. Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19. Nat Genet. 2004;36(9):1003–7. doi: 10.1038/ng1406. PubMed PMID: 15286788.

    CrossRefPubMedWeb of ScienceGoogle Scholar
26. 26.↵
    Kleta R, Romeo E, Ristic Z, Ohura T, Stuart C, Arcos-Burgos M, Dave MH, Wagner CA, Camargo SR, Inoue S, Matsuura N, Helip-Wooley A, Bockenhauer D, Warth R, Bernardini I, Visser G, Eggermann T, Lee P, Chairoungdua A, Jutabha P, Babu E, Nilwarangkoon S, Anzai N, Kanai Y, Verrey F, Gahl WA, Koizumi A. Mutations in SLC6A19, encoding B⁰AT1, cause Hartnup disorder. Nat Genet. 2004;36(9):999–1002. doi: 10.1038/ng1405. PubMed PMID: 15286787.

    CrossRefPubMedWeb of ScienceGoogle Scholar
27. 27.↵
    Broer A, Klingel K, Kowalczuk S, Rasko JE, Cavanaugh J, Broer S. Molecular cloning of mouse amino acid transport system B0, a neutral amino acid transporter related to Hartnup disorder. J Biol Chem. 2004;279(23):24467–76. doi: 10.1074/jbc.M400904200. PubMed PMID: 15044460.

    Abstract/FREE Full TextGoogle Scholar
28. 28.↵
    Penmatsa A, Wang KH, Gouaux E. X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature. 2013;503(7474):85–90. doi: 10.1038/nature12533. PubMed PMID: 24037379; PMCID: PMC3904663.

    CrossRefPubMedGoogle Scholar
29. 29.↵
    Coleman JA, Green EM, Gouaux E. X-ray structures and mechanism of the human serotonin transporter. Nature. 2016;532(7599):334–9. doi: 10.1038/nature17629. PubMed PMID: 27049939; PMCID: PMC4898786.

    CrossRefPubMedGoogle Scholar
30. 30.↵
    Yan R, Zhao X, Lei J, Zhou Q. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex. Nature. 2019. doi: 10.1038/s41586-019-1011-z. PubMed PMID: 30867591.

    CrossRefPubMedGoogle Scholar
31. 31.↵
    Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, Seidah NG, Nichol ST. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005;2:69. doi: 10.1186/1743-422X-2-69. PubMed PMID: 16115318; PMCID: PMC1232869.

    CrossRefPubMedGoogle Scholar
32. 32.↵
    Lee Y, Wiriyasermkul P, Jin C, Quan L, Ohgaki R, Okuda S, Kusakizako T, Nishizawa T, Oda K, Ishitani R, Yokoyama T, Nakane T, Shirouzu M, Endou H, Nagamori S, Kanai Y, Nureki O. Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc. Nat Struct Mol Biol. 2019;26(6):510–7. doi: 10.1038/s41594-019-0237-7. PubMed PMID: 31160781.

    CrossRefPubMedGoogle Scholar
33. 33.↵
    Shulla A, Heald-Sargent T, Subramanya G, Zhao J, Perlman S, Gallagher T. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J Virol. 2011;85(2):873–82. doi: 10.1128/JVI.02062-10. PubMed PMID: 21068237; PMCID: PMC3020023.

    Abstract/FREE Full TextGoogle Scholar
34. 34.↵
    Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, Pohlmann S. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol. 2014;88(2):1293–307. doi: 10.1128/JVI.02202-13. PubMed PMID: 24227843; PMCID: PMC3911672.

    Abstract/FREE Full TextGoogle Scholar
     https://jvi.asm.org/content/88/2/1293?ijkey=c54b09b4431c63e8e642702704460d7d6deedcda&keytype2=tf_ipsecsha